Abstract
In patients admitted for acute stroke, the clinical burden of acute myocardial infarction (AMI) and acute heart failure (AHF) is unclear. In these patients we evaluated: (1) the prevalence of AMI and AHF; (2) the effect of AMI and/or AHF on mortality at 3 months; (3) the risk factors for AMI and/or AHF. Consecutive patients admitted for acute stroke were prospectively assessed for the occurrence of AMI and AHF during the hospital stay. Mortality at 3 months was also assessed. Multiple logistic regression analysis was used to identify independent predictors for cardiovascular events and death. Eight hundred fourteen patients were included in the study, 685 of which had an ischemic stroke (84.2%). Fifty-three patients (6.5%) had an AMI and/or an AHF (13 AMI alone, 28 AHF alone and 12 AMI and AHF); all these events occurred in patients with ischemic stroke. At 3 months, 151 patients had died (18.8%). Among patients who had an AMI and/or AHF, 60.4% died as compared with 119 of the 750 patients who did not have these events (15.9%) (p < 0.0001). At logistic regression analysis, AMI and/or AHF were associated with increased mortality at 3 months (p = 0.001). History of angina (p = 0.003), AMI in the 3 months before admission (p < 0.0001), hyperglycemia (p = 0.047), and high NIHSS on admission (p < 0.0001) were associated with in hospital AMI and/or AHF. In acute stroke patients, AMI and AHF are common and associated with increased mortality at 3 months. Whether a timely and more careful management of these complications may improve clinical outcome should be further explored.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams RJ, Chimowitz MI, Alpert JS et al (2003) Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation 108:1278–1290
Touze’ E, Varenne O, Chatellier G et al (2005) Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke. A systematic review and meta-analysis. Stroke 36:2748–2755
Paciaroni M, Silvestrelli G, Caso V et al (2003) Neurovascular territories involved in different etiological subtype of ischemic stroke in the Perugia Stroke Registry. Eur J Neurol 10:361–365
Silvestrelli G, Corea F, Paciaroni M et al (2002) The Perugia hospital-based Stroke Registry: report of the 2nd year. Clin Exp Hypertens 24:485–491
Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke: definition for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41
World Health Organization (1989) Stroke—1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 20:1407–1431
Alpert JS, Thygesen K, Antman E et al (2000) The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959–969
Jaffe AS (2006) Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 48:1763–1764
Thygesen K, Alpert JS, White HD (2007) On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 116:2634–2653
ESC Guidelines for the diagnosis, treatment of acute, chronic heart failure (2008) The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933–989
Sacco RL, Adams R, Albers G et al (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke Co-Sponsored by the Council on Cardiovascular Radiology and Intervention. Circulation 113:e409–e449
SPSS for Windows. Chicago: SPSS 2003 (Software)
Liao J, O’Donnell MJ, Silver FL et al (2009) In-hospital myocardial infarction following acute ischaemic stroke: an observational study. Eur J Neurol 16:1035–1040
Bath PM, Iddenden R, Bath FJ (2000) Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 31:1770–1778
Enlimomab Acute Stroke Trial Investigators (2001) Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57:1428–1434
LiLAC Study Group (2008) Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. J Neurol Neurosurg Psychiatry 79:895–899
Prosser J, MacGregor L, Lees KR et al (2007) Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 38:2295–2302
Amarenco P, Lavallée PC, Labreuche J et al (2011) Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke 42(1):22–29
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Micheli, S., Agnelli, G., Caso, V. et al. Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. J Neurol 259, 106–110 (2012). https://doi.org/10.1007/s00415-011-6136-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6136-4